Stay updated on Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page.

Latest updates to the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedA new Revision: v3.5.4 was added to the page and the previous Revision: v3.5.3 was removed, indicating an update to the page's revision history.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now reflects an updated ClinicalTrials.gov frontend revision (v3.5.3) instead of the previous one (v3.5.2), indicating a site release rather than a change to the trial’s content.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision updated: added Revision v3.5.2 and removed Revision v3.5.0.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision: v3.5.0 was added. Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check103 days agoChange DetectedThe page now shows Revision: v3.4.2 and no longer displays Revision: v3.4.1, indicating a minor site version update; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page.